drugset

drugset / Trial / NCT01699152

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT01699152 ↗

Phase 1 Completed 16 enrolled Tragara Pharmaceuticals, Inc.

NaSingle-groupOpen-labelTreatment

Summary

This is a multi-center, open-label, dose escalation study.

Timeline

Start: 2012-09
Primary completion: 2015-07
Completion: 2016-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zotiraciclib	Small molecule	—	Oral

Indications